Calmadin en es it fr

Calmadin Brand names, Calmadin Analogs

Calmadin Brand Names Mixture

  • No information avaliable

Calmadin Chemical_Formula

C20H23NS

Calmadin RX_link

No information avaliable

Calmadin fda sheet

Calmadin msds (material safety sheet)

Calmadin Synthesis Reference

No information avaliable

Calmadin Molecular Weight

309.469 g/mol

Calmadin Melting Point

< 25 oC

Calmadin H2O Solubility

Soluble as HCl salt

Calmadin State

Liquid

Calmadin LogP

5.7

Calmadin Dosage Forms

Tablets (oral, 1 mg)

Calmadin Indication

Used for the symptomatic treatment of parkinsonism.

Calmadin Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Calmadin Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Calmadin side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Calmadin Patient Information

Calmadin Organisms Affected

Humans and other mammals